Enzymotec Ltd., a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that it was granted patents by the U.S. Patent and Trademark Office and by IP Australia. The newly granted patents cover certain phospholipid compositions which include long chain poly-unsaturated fatty acids and are relevant for several of Enzymotec’s products such as Krill oil and other omega 3 products.
Enzymotec’s patents are like master patents in that they cover wide variety of phospholipid based compositions that include long chain poly-unsaturated fatty acids, and are pertinent to a number of Enzymotec’s products, such as the K•REAL® krill oil products and additional advanced phospholipid products. These additions to Enzymotec’s broad patent portfolio are the result of the Company’s efforts to continually maintain and reinforce the protection of its products.
Dr. Ariel Katz, President and Chief Executive Officer of Enzymotec, commented, “As experts in specialty phospholipid-based products, we are excited by the further strengthening of our portfolio of intellectual property with these important patents. Our products are strong leaders in the market, driven by our specialized technologies and supported with an enforceable patent portfolio. These new patents are demonstrative of our commitment to innovation and provide our customers with exceptional ingredients of the highest quality.”
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. We develop, manufacture and market innovative bio-functional lipid ingredients, as well as final products, based on sophisticated proprietary processes and technologies.
For more information, visit www.enzymotec.com.